MODULATION OF [H-3] SEROTONIN RELEASE BY DIHYDROPYRIDINES IN SPINAL-CORD SYNAPTOSOMES

被引:11
作者
GANDHI, VC
JONES, DJ
机构
[1] UNIV TEXAS,HLTH SCI CTR,DEPT ANESTHESIOL,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284
[2] UNIV TEXAS,HLTH SCI CTR,DEPT PHARMACOL,SAN ANTONIO,TX 78284
关键词
5-HT release; Ca[!sup]2+[!/sup] channels (voltage-dependent); Dihydropyridines; Spinal cord; Synaptosomes; ω-Conotoxin;
D O I
10.1016/0014-2999(90)90013-V
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The release of [3H]monoamines from preloaded synaptosomes from spinal cord is K+-dependent and can be modulated by L-type Ca2+ channel agonists such as the 1,4-dihydropyridine (1,4-DHP), Bay K 8644. Whereas the basal release of [3H]monoamines was not altered by Bay K 8644, K+-stimulated release of [3H]norepinephrine was enhanced 35% and [3H]serotonin 50%. Modulation of release by Bay K 8644 was dependent on the K+ concentration in the medium, being present only at submaximal depolarization with 15 mM K+. Enhanced release in the presence of Bay K 8644 was concentration-dependent and Ca2+-dependent. Ca2+-independent release induced by fenfluramine was not enhanced by Bay K 8644. Both nimodipine and nitrendipine, 1,4-DHP antagonists, produced a concentration-dependent block of the Bay K 8644-induced monoamine release and had no independent effect on basal or K+-stimulated release. ω-Conotoxin GVIA (ω-CgTx) produced a concentration dependent decrease of K+-stimulated serotonin release, which antagonized the stimulatory effect of low concentrations of Bay K 8644. However, ω-CgTx did not alter the enhancement of K+-stimulated release at higher concentrations of Bay K 8644. The data from the present work establish the conditions for modulation of K+-evoked monoamine release in spinal cord by 1,4-DHP agonists and suggest a role for the L-type voltage dependent Ca2+ channel in this process. © 1990.
引用
收藏
页码:271 / 280
页数:10
相关论文
共 36 条
[1]   PROTEIN-KINASE-C ACTIVATION AND ALPHA-2-AUTORECEPTOR-MODULATED RELEASE OF NORADRENALINE [J].
ALLGAIER, C ;
HERTTING, G ;
HUA, YH ;
JACKISCH, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (01) :161-172
[2]   CALCIUM ACTION IN SYNAPTIC TRANSMITTER RELEASE [J].
AUGUSTINE, GJ ;
CHARLTON, MP ;
SMITH, SJ .
ANNUAL REVIEW OF NEUROSCIENCE, 1987, 10 :633-693
[3]   CA-2+ AGONISTS - NEW, SENSITIVE PROBES FOR CA-2+ CHANNELS [J].
BECHEM, M ;
HEBISCH, S ;
SCHRAMM, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (07) :257-261
[4]   CHARACTERIZATION OF THE OMEGA-CONOTOXIN TARGET - EVIDENCE FOR TISSUE-SPECIFIC HETEROGENEITY IN CALCIUM-CHANNEL TYPES [J].
CRUZ, LJ ;
JOHNSON, DS ;
OLIVERA, BM .
BIOCHEMISTRY, 1987, 26 (03) :820-824
[5]  
CRUZ LJ, 1986, J BIOL CHEM, V261, P6230
[6]   CA-45(2+) UPTAKE INTO RAT WHOLE BRAIN SYNAPTOSOMES UNALTERED BY DIHYDROPYRIDINE CALCIUM-ANTAGONISTS [J].
DANIELL, LC ;
BARR, EM ;
LESLIE, SW .
JOURNAL OF NEUROCHEMISTRY, 1983, 41 (05) :1455-1459
[7]  
De Sousa B.N., 1979, DEV NEUROSCI, V2, P115
[8]   INHIBITION OF CENTRAL NEUROTRANSMITTER RELEASE BY OMEGA-CONOTOXIN GVIA, A PEPTIDE MODULATOR OF THE N-TYPE VOLTAGE-SENSITIVE CALCIUM-CHANNEL [J].
DOOLEY, DJ ;
LUPP, A ;
HERTTING, G .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1987, 336 (04) :467-470
[9]   OMEGA-CONOTOXIN GVIA AND PHARMACOLOGICAL MODULATION OF HIPPOCAMPAL NORADRENALINE RELEASE [J].
DOOLEY, DJ ;
LUPP, A ;
HERTTING, G ;
OSSWALD, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 148 (02) :261-267
[10]  
FISCHER JB, 1983, J PHARMACOL EXP THER, V225, P623